[HTML][HTML] Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis
Background Human immunodeficiency virus (HIV) infection is the strongest risk factor for
developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan Africa. In …
developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan Africa. In …
Scaling up interventions to achieve global tuberculosis control: progress and new developments
M Raviglione, B Marais, K Floyd, K Lönnroth… - The Lancet, 2012 - thelancet.com
Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet
tuberculosis series provided a comprehensive overview of global control efforts and …
tuberculosis series provided a comprehensive overview of global control efforts and …
[图书][B] Essentials of qualitative inquiry
MJ Mayan - 2016 - taylorfrancis.com
This brief, inexpensive guide introduces students and novices to the key elements of
qualitative research methods. Written in a friendly, conversational style, replete with good …
qualitative research methods. Written in a friendly, conversational style, replete with good …
A trial of early antiretrovirals and isoniazid preventive therapy in Africa
Temprano ANRS 12136 Study … - New England Journal of …, 2015 - Mass Medical Soc
Background In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)–
associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess …
associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess …
[PDF][PDF] Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings
World Health Organization - 2011 - apps.who.int
All members of the Guidelines Group were asked to complete a World Health Organization
(WHO) declaration of interest form and only two declared a conflict of interest. These were …
(WHO) declaration of interest form and only two declared a conflict of interest. These were …
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
Background Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more
common in people with HIV than in people without HIV. We aimed to assess the effect of …
common in people with HIV than in people without HIV. We aimed to assess the effect of …
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
Background In accordance with WHO guidelines, people with HIV infection in Botswana
receive daily isoniazid preventive therapy against tuberculosis without obtaining a tuberculin …
receive daily isoniazid preventive therapy against tuberculosis without obtaining a tuberculin …
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis
A Cattamanchi, R Smith, KR Steingart… - JAIDS Journal of …, 2011 - journals.lww.com
Objective: To determine whether interferon-gamma release assays (IGRAs) improve the
identification of HIV-infected individuals who could benefit from latent tuberculosis infection …
identification of HIV-infected individuals who could benefit from latent tuberculosis infection …
[图书][B] WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders
World Health Organization - 2012 - apps.who.int
The human immunodeficiency virus (HIV) pandemic presents a significant challenge to
global tuberculosis (TB) control. TB is a leading preventable cause of death among people …
global tuberculosis (TB) control. TB is a leading preventable cause of death among people …
[HTML][HTML] Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano …
Background Temprano ANRS 12136 was a factorial 2× 2 trial that assessed the benefits of
early antiretroviral therapy (ART; ie, in patients who had not reached the CD4 cell count …
early antiretroviral therapy (ART; ie, in patients who had not reached the CD4 cell count …